Platelet function in myeloproliferative disorders: Characterization and sequential studies show multiple platelet abnormalities, and change with time

European Journal of Haematology

Volumn 40, Issue 3, 1988, Pages 267-272

  Baker, R I ^a   Manoharan, A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

myeloproliferative disorder; platelet function

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID;

ADULT; BIOLOGICAL MODEL; BLEEDING DISORDER; CELL CULTURE; CYTOCHEMISTRY; CYTOLOGY; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS;

AGED; ASPIRIN; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMAN; MALE; MIDDLE AGE; MYELOPROLIFERATIVE DISORDERS; PLATELET AGGREGATION; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 0023898222     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1988.tb00835.x     Document Type: Article

References (24)

1. Platelet dysfunction in myeloproliferative syndromes
2. Defective platelet aggregation and increased platelet turnover in patients with myelofibrosis and other myeloproliferative diseases
3. Abnormalities of epinephrine‐induced platelet aggregation and adenine nucleotides in myeloproliferative disorder
4. Platelet adenine nucleotides and arachidonic acid metabolism in the myeloproliferative disorders
5. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders
6. Platelet function in essential thrombocythemia: Decreased epinephrine responsiveness associated with a deficiency of platelet α adrenergic receptors
7. Evidence for a platelet membrane defect in the myeloproliferative syndromes
8. Essential thrombocythemia and peripheral gangrene
9. Platelet hyperaggregability and thrombosis in patients with thrombocythemia
10. Aspirin ingestion in primary thrombocythemia
11. In vivo platelet release in myeloproliferative disorders
12. Bleeding and thrombosis in the myeloproliferative disorders
13. Thrombocytosis and thrombocythaemia
14. Prognostic factors in myelofibrosis
15. Metabolic control and its influence on platelet and coagulation abnormalities in type I diabetes mellitus
16. Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders
17. Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers
18. Acetylation of prostaglandin synthase by aspirin
19. 2‐like material and platelet release inducing activity in plasma
20. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides
21. Different effects of thromboxane synthetase inhibitors on platelets from different individuals
22. Deficiency of platelet lipoxygenase activity in myeloproliferative disorders
23. Template bleeding time and clinical haemorrhage in myeloproliferative disease
24. Platelet function abnormalities in the myeloproliferative disorders